BioSpace News Archive

Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is excited to announce a partnership with Holberg EEG AS.

Today Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership with EnviroTech Water Treatment, a leading manufacturer and supplier of antiseptic hand sanitizers.

TRAX International Corporation (“TRAX”), a leading provider of professional and technical services to U.S. federal government agencies, today announced it was awarded a contract to support the Battelle CCDS Critical Care Decontamination Systems™ in the fight against the pandemic outbreak.

Neuronetics, Inc. (Nasdaq: STIM), today announced that its 2020 Annual Meeting of Stockholders will be held solely via live webcast due to the public health impact of the COVID-19 pandemic and out of an abundance of concern for the health and wellbeing of our employees, stockholders and directors.

Coagulopathy, or abnormal blood clotting, has been reported as a complication associated with increased risk of death in patients with COVID-19.

Varian (NYSE: VAR) today announced that Dow Wilson, Chief Executive Officer, J. Michael Bruff, Chief Financial Officer, and Anshul Maheshwari, Vice President, Investor Relations and Treasurer, will participate in a virtual fireside chat at the UBS Virtual Global Healthcare Conference at 1:20 p.m. EDT on Monday, May 18, 2020.

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, hosted a KOL symposium today with Dr. Eric Tran, Assistant Member at the Earle A. Chiles Research Institute in the Providence Cancer Institute reflecting on the T cell therapy landscape, while Genocea provided an in-depth profile of GEN-011 – Genocea’s neoantigen cell therapy.

Taro Pharmaceutical Industries Ltd. announced that it plans to release its financial results for year ended March 31, 2020, on Tuesday, May 19, 2020.

On May 14, 2020 Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, will be participating in and sponsoring a PharmaVOICE virtual panel event.

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced it will be offering COVID-19 testing for nursing homes in the state of Mecklenburg-Western Pomerania, Germany - the location of the Company’s headquarters.